CS logo
small CS logo
Instituto do Câncer de São Paulo - ICESP

Sao Paulo, Sao Paulo, Brazil
Centro de tratamento de câncer em São Paulo

About Instituto do Câncer de São Paulo - ICESP


Instituto do Câncer de São Paulo Octavio Frias de Oliveira é um centro de atendimento médico e hospitalar que funciona como autarquia vinculada ao Governo do Estado de São Paulo.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Instituto do Câncer de São Paulo - ICESP


During the past decade, Instituto do Câncer de São Paulo - ICESP conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto do Câncer de São Paulo - ICESP" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Instituto do Câncer de São Paulo - ICESP


According to Clinical.Site data, the most researched conditions in "Instituto do Câncer de São Paulo - ICESP" are "Gastric Cancer" (1 trials), "Peritoneal Carcinomatosis" (1 trials) and "Renal Cell Carcinoma (RCC)" (1 trials). Many other conditions were trialed in "Instituto do Câncer de São Paulo - ICESP" in a lesser frequency.

Clinical Trials Intervention Types at Instituto do Câncer de São Paulo - ICESP


Most popular intervention types in "Instituto do Câncer de São Paulo - ICESP" are "Combination Product" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Epacadostat" (1 trials), "Intraperitoneal chemotherapy" (1 trials), "Pazopanib" (1 trials), "Pembrolizumab" (1 trials) and "Sunitinib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Instituto do Câncer de São Paulo - ICESP


The vast majority of trials in "Instituto do Câncer de São Paulo - ICESP" are 2 trials for "All" genders.

Clinical Trials Status at Instituto do Câncer de São Paulo - ICESP


Currently, there are NaN active trials in "Instituto do Câncer de São Paulo - ICESP". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Instituto do Câncer de São Paulo - ICESP, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Instituto do Câncer de São Paulo - ICESP, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".